跳至主要内容
临床试验/NCT06946914
NCT06946914招募中4 期

Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns

Kafrelsheikh University1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年6月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
160
试验地点
1
主要终点
the incidence of Transient tachypnea of the newborn which defined by increase respiratory rate more than 60 cycle per minute in pregnant women with gestational age less than 38 weeks before elective cesarean section

研究概览

简要总结

The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.

详细描述

Caesarean section is one of the most common carried out surgical procedures in modern obstetrics. About 18.5 million caesarean section are conducted yearly worldwide, and 21-33% of all caesarean section are performed in middle and high-income countries.

The most frequent complications that are seen in neonates include respiratory morbidity, hypoglycemia, sepsis, and admission to the neonatal intensive care unit (NICU). The family and caregivers are affected in many ways when a newborn is admitted to the intensive care unit.

Both preterm and term infants delivered by caesarean section have been reported to experience respiratory distress syndrome, which is brought on by a surfactant deficiency.

Respiratory distress (RD) affects about 27% of babies born, and it is more common in newborns delivered by elective cesarean section (ECS) than in emergency CS or vaginally.

In the neonatal intensive care unit, neonatal respiratory distress syndrome (NRDS), which is mostly brought on by pulmonary surfactant insufficiency after delivery, is acknowledged as one of the most frequent causes of respiratory distress in newborn preterm infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with indication for elective caesarean section.
  • Age less than 35 years old.
  • Gestational age less than 38 weeks.
  • Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
  • Singleton pregnancy with no major anomalies

排除标准

  • Any obstetric disorders as preeclampsia and diabetes.
  • Fetus with oligohydramnios, intrauterine growth restriction.
  • Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.
  • History of more than or equal 2 previous caesarean section.

研究组 & 干预措施

Misoprostol before elective cesarean section .

Active Comparator

candidates will receive 100mcg Misoprostol one hour before elective caesarean section.

干预措施: Misoprostol (Drug)

Giving no treatment before elective caesarean section.

Placebo Comparator

candidates will receive no treatment before elective caesarean section.

干预措施: Misoprostol (Drug)

结局指标

主要结局

the incidence of Transient tachypnea of the newborn which defined by increase respiratory rate more than 60 cycle per minute in pregnant women with gestational age less than 38 weeks before elective cesarean section

时间窗: in the first 5 minute after delivery of fetus post operative

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Merna Ashraf Ahmed Farid

gynaecologist and obsteterician resident

Kafrelsheikh University

研究点 (1)

Loading locations...

相似试验